Integrated control of lower urinary tract--clinical perspective
- PMID: 16465178
- PMCID: PMC1751494
- DOI: 10.1038/sj.bjp.0706629
Integrated control of lower urinary tract--clinical perspective
Abstract
The neural mechanisms that determine social bladder control are reviewed, with a particular emphasis on the role played by sensation in the process. Much has been learnt about the neural control of the bladder from studying patients with neurological disease and those disorders that are known to disrupt bladder storage are described. Possible approaches to treatment of the resulting incontinence are reviewed and it is acknowledged that in the future, the optimal treatment for incontinence may be determined by its precise underlying pathophysiology in each instance, for example, suprapontine causes requiring different medication to spinal causes. Although the main emphasis of urological research and development so far has been the treatment of incontinence, effective therapy for other bladder disorders such an impaired emptying or bladder pain could have an important impact on the bladder symptoms of many patients.
Figures
References
-
- ABRAMS P., CARDOZO L., FALL M., GRIFFITHS D., ROSIER P., ULMSTEN U., VAN KERREBROECK P.E., VICTOR A., WEIN A. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol. Urodyn. 2002;21:167–178. - PubMed
-
- ANDERSSON K.E. Antimuscarinics for treatment of overactive bladder. Lancet Neurol. 2004;3:47–53. - PubMed
-
- ANDREW J., NATHAN P.W. Lesions of the anterior frontal lobes and disturbances of micturition and defaecation. Brain. 1964;87:233–262. - PubMed
-
- APOSTOLIDIS A., BRADY C.M., YIANGOU Y., DAVIS J., FOWLER C.J., ANAND P. Capsaicin receptor TRPV1 in the urothelium of neurogenic human bladders and the effect of intravesical resiniferatoxin. Urology. 2005;65:400–405. - PubMed
-
- APOSTOLIDIS A., DASGUPTA P., FOWLER C.J.2006Hypothesis for the remarkable efficacy of injected botulinum toxin in the treatment of human detrusor overactivity (DO) Eur. Urol.(in press). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
